SEC Form 4 · accession 0001225208-16-023885
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin J. Ballinger
Officer — SVP & Pres, Interven Cardio
Period of report
Jan 7, 2016
Accepted (ET)
Jan 7, 2016 · 4:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 7, 2016 | S | 19,059 | $17.7253 | D | 30,323 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.63 to $17.85, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.